
Dr. Beata Halassy, a virologist, successfully treated her own recurring stage 3B breast cancer by self-administering a novel virotherapy after conventional chemotherapy failed. Cancer cells, characterized by broken self-destruct mechanisms and an inability to signal the immune system, are uniquely susceptible to viral infection. By injecting weakened measles and VSV viruses directly into her tumor, Halassy bypassed the cancer's protective chemical shield, triggering an aggressive immune response that decimated the mass. This experimental approach reduced the tumor by 63% and prevented recurrence for over six years. While this method highlights the potential of virotherapy as a less toxic, effective alternative to traditional treatments, it also underscores the tension between rigid medical safety protocols and the need for faster, more accessible innovation for patients facing terminal diagnoses.
Sign in to continue reading, translating and more.
Open full episode in Podwise